
HiLabs is a healthcare technology company that specializes in cleaning and transforming dirty data to unlock its hidden potential. Their proprietary AI-powered technology delivers immediate ROI by enhancing member experiences, improving provider data accuracy, and increasing payment accuracy. HiLabs helps health plans address complex data quality problems, leading to measurable improvements in operational efficiency and outcomes. Their core products include MCheck™ Provider, MCheck™ Clinical, MCheck™ VBC, MCheck™ Roster Automation, and MCheck™ Network IQ, all designed to harmonize healthcare data and support value-based care initiatives. The company emphasizes a collaborative culture, innovation, and provides significant growth opportunities for its employees, aiming to transform the health-tech landscape.

HiLabs is a healthcare technology company that specializes in cleaning and transforming dirty data to unlock its hidden potential. Their proprietary AI-powered technology delivers immediate ROI by enhancing member experiences, improving provider data accuracy, and increasing payment accuracy. HiLabs helps health plans address complex data quality problems, leading to measurable improvements in operational efficiency and outcomes. Their core products include MCheck™ Provider, MCheck™ Clinical, MCheck™ VBC, MCheck™ Roster Automation, and MCheck™ Network IQ, all designed to harmonize healthcare data and support value-based care initiatives. The company emphasizes a collaborative culture, innovation, and provides significant growth opportunities for its employees, aiming to transform the health-tech landscape.
Sector: Healthcare data management / health-tech
Flagship product: MCheck™ platform (provider, clinical, VBC, roster automation, Network IQ)
Latest disclosed round: Series B, $39M (Mar 14, 2024)
Compliance: HIPAA, SOC 2 Type II, HITRUST
Employees: Approximately 275
Dirty, inconsistent healthcare data across provider directories, rosters, clinical and administrative systems that hinders care delivery and payment accuracy.
2014
Health technology / Healthcare data
39000000.00
Round included participation from F-Prime Capital and other investors.